Breast cancer (invasive) · None

Deterministic view of the source YAML entity. Clinical authority remains with the cited source IDs and reviewer sign-off state.

Knowledge-base record for audit. Provisional clinical content: this is not a prescription. An oncologist must verify original sources, applicability and review status. Full rules and constraints are in the YAML.

Source YAML: complete record

Track	standard
Linked regimen	`None`

ID	`IND-BRCA-HBOC-SUSPICION-PREVENTION-GENETIC-COUNSELING`
Type	Indication
Status	reviewed 2026-05-18 \| pending_clinical_signoff
Diseases	`DIS-BREAST`
Sources	`SRC-ESMO-BREAST-EARLY-2024` `SRC-ESMO-OVARIAN-2024` `SRC-NCCN-BREAST-2025` `SRC-NCCN-OVARIAN-2025`

Notes

STUB — v0.2-B hereditary pilot for BRCA / HBOC. NCCN Genetic/Familial High-Risk Breast/Ovarian/Pancreatic as a new SRC entity is v0.2-B authoring backlog (per scope proposal open question

Used By

Indication

IND-BRCA-HBOC-SUSPICION-PREVENTION-ENHANCED-SURVEILLANCE - IND-BRCA-HBOC-SUSPICION-PREVENTION-ENHANCED-SURVEILLANCE

Red flag

RF-BRCA-HBOC-FAMILY-HISTORY-SUSPICION - Family pedigree meeting criteria suggestive of Hereditary Breast and Ovarian Cancer (HBOC...